Academic yr: <<< Previous 2014 2015 2016 | 2017 | 2018 Next >>>
 化学療法・緩和ケア科
Summary Research grants & projects Published papers
Books Academic conference presentation


Professor:

   Hayashi Kazuhiko
Associate Professor:
   Kawakami Kazuyuki
Assistant Professor:
   Takeshita Nobuhiro
Assistant Professor:
   Nakajima Gou
■ Summary
To the top
■ Research grants & projects
To the top
■ Research works
Journal Book Presentation Other presentations
JapaneseEnglish JapaneseEnglish Domesticinternational
First authorCorresponding
Author
Co-authorFirst authorCorresponding
Author
Co-author First authorCo-authorFirst authorCo-author PresenterCo-presenterPresenterCo-presenter PresenterCo-presenter
 0 0 3 0 0 2  0 2 0 0  0 8  0 3  0 2
To the top
■ Published papers
Original article
1. Kuramochi Hidekazu, Ando Masayuki, Itabashi Michio, Nakajima Go, Kawakami Kazuyuki, Hamano Mie, Hirai Eiichi, Yokomizo Hajime, Okuyama Ryuji, Araida Tatsuo, Yoshimatsu Kazuhiko, Kameoka Shingo, Hayashi Kazuhiko:  Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab.  Cancer chemotherapy and pharmacology  79 (3) :579-585 , 2017.3   DOI:10.1007/s00280-017-3255-3
2. Nishina Tomohiro, Moriwaki Toshikazu, Shimada Mitsuo, Higashijima Jun, Sakai Yoshinori, Masuishi Toshiki, Ozeki Mitsuharu, Amagai Kenji, Negoro Yuji, Indo Shunju, Denda Tadamichi, Sato Mikio, Yamamoto Yuji, Nakajima Go, Mizuta Minoru, Takahashi Ikuo, Hiroshima Yoshinori, Ishida Hiroyasu, Maeba Takashi, Hyodo Ichinosuke:  Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).  Clinical colorectal cancer  15 (3) :236-42 , 2016.9   DOI:10.1016/j.clcc.2015.12.001
Case report
1. 岡野 美々, 中島 豪, 倉持 英和, 林 和彦:  5-FUに起因する高アンモニア血症から意識障害を来した再発大腸癌の1例.  千葉医学雑誌  92 (3) :91-95 , 2016.6
2. 椎原正尋, 樋口亮太, 梶山英樹, 谷澤武久, 岡野美々, 竹下信啓, 林和彦, 古川徹, 山本雅一*:  中部胆管癌原発小細胞癌の1例.  日本消化器外科学会雑誌  49 (5) :418-425 , 2016.5
Other
1. 林 浩志, 三輪 由加里, 近藤 侑鈴, 川上 和之, 林 和彦:  がん分子標的治療にかかわる臨床検査・遺伝子検査】分子標的薬の治療効果判定におけるCTC検査の可能性.  臨床検査  60 (13) :1580-1585 , 2016.12
To the top
■ Books
1. 林和彦:  子どもと一緒に知る「がん」になるってどんなこと?.  「がん」になるってどんなこと?  1-222.  セブン&アイ出版,  東京, 2017.2
2. 中島 豪, 井原 世尊, 近藤 侑鈴, 竹下 信啓, 川上 和之, 林 和彦:  カテコール-O-メチルトランスフェラーゼ(COMT)遺伝子多型とオピオイドの必要量についての検討.  Palliative Care Research  S301.  (NPO)日本緩和医療学会,  日本, 2016.6
To the top
■ Academic conference presentation
1. ◎YAGAWA Yohsuke, ARUGA Atsushi, TAKESHITA Nobuhiro, HIGUCHI Ryota, YAZAWA Takehisa, KOBAYASHI Makio, YAMAMOTO Msakazu: Involvement of chemokine peceptor expression and lymph node metastasis in disral cholangiocarcinoma.  AHPBA2017,  Florida,  2017/03
2. ◎YAGAWA Yohsuke, HIGUCHI Ryota, YAZAWA Takehisa, UEMURA Shuichiro, MATSUNAGA Yutaro, TAKESHITA Honihiro, YAMAMOTO Msakazu: Postoperative characteristic issues of congenital dilatation of the intra-and extrahepatic bile duct.  AHPBA2017,  Florida,  2017/03
3. NAKAJIMA GO, Kuramochi Hidekazu, Ando Masayuki, Itabashi Michio, Kawakami Kazuyuki, Hamano Mie, Hirai Eiichi, Iino Takayuki, Yokomizo Hajime, Okuyama Ryuji, Araida Tatsuo, Yoshimatsu Kazuhiko, Kameoka Shingo, Hayashi Kazuhiko: A phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidine, oxaliplatin, and bevacizumab.  AACR 107th Annual Meeting,  New Orleans, LA, USA,  2016/04
4. ◎倉持英和, 中島豪, 金子由香, 山本雅一, 林和彦, 新井田達雄: Amphiregulin, Epiregulinの大腸癌抗EGFR抗体薬効果予測マーカーとしての有用性の検討.  第54回日本癌治療学会学術集会,  横浜,  2016/10
5. ◎板橋道朗, 倉持英和, 安藤昌之, 中島豪, 川上和之, 濱野美枝, 横溝肇, 新井田達雄, 吉松和彦, 林和彦: 口演1-7大腸癌薬物療法①
フッ化ピリミジン、オキサリプラチン、ベバシズマブ既治療進行大腸癌に対するベバシズマブ+イリノテカン療法の多施設第二相試験.  第14回日本臨床腫瘍学会学術集会,  神戸,  2016/07
Display all(13)
To the top
  :Corresponding Author
 :First Author
◎:Presenter